UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annals of epidemiology, ISSN 1047-2797, 12/2018, Volume 28, Issue 12, pp. 841 - 849
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 07/2017, Volume 75 Suppl 3, pp. S383 - S391
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | HIV Infections - prevention & control | Heterosexuality | Pre-Exposure Prophylaxis - utilization | Humans | Middle Aged | Substance Abuse, Intravenous - epidemiology | HIV Infections - psychology | Male | Patient Acceptance of Health Care - statistics & numerical data | Health Knowledge, Attitudes, Practice | Young Adult | Homosexuality, Male | Adolescent | Adult | Female | Post-Exposure Prophylaxis - utilization | Sexual Partners | New York - epidemiology | Health Education - statistics & numerical data | Index Medicus | AIDS/HIV
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2019, Volume 321, Issue 22, pp. 2203 - 2213
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV Infections - prevention & control | United States - epidemiology | Anti-Retroviral Agents - therapeutic use | Emtricitabine - adverse effects | Emtricitabine - therapeutic use | Tenofovir - adverse effects | Risk Assessment | Tenofovir - therapeutic use | Administration, Oral | Humans | Risk Factors | Anti-Retroviral Agents - adverse effects | Male | Advisory Committees | Pre-Exposure Prophylaxis | Medication Adherence | Acquired Immunodeficiency Syndrome - epidemiology | Female | Drug Therapy, Combination | Health care | Emtricitabine | Therapy | Task forces | Prophylaxis | Health risks | Risk reduction | Infections | Males | Adhesion | Antiretroviral therapy | Subgroups | Prevention | Tenofovir | Antiretroviral agents | Risk assessment | Human immunodeficiency virus--HIV | Diagnostic software | Diagnostic systems | Condoms | Females | Index Medicus | Abridged Index Medicus
Journal Article
HIV medicine, ISSN 1464-2662, 11/2020, Volume 21, Issue 10, pp. 668 - 670
HIV | pre‐exposure prophylaxis | post‐exposure prophylaxis | post-exposure prophylaxis | pre-exposure prophylaxis | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | HIV (Viruses) | Clinics | Sexually transmitted diseases--STD | Exposure | Human immunodeficiency virus--HIV | Prophylaxis | Health risks | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2015, Volume 372, Issue 6, pp. 509 - 518
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV Infections - prevention & control | Humans | Middle Aged | Drug Resistance, Viral | Administration, Intravaginal | Deoxycytidine - blood | Adenine - blood | Tenofovir | Young Adult | Adenine - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Organophosphonates - blood | Surveys and Questionnaires | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | HIV Seropositivity | Administration, Oral | HIV-1 - drug effects | Deoxycytidine - administration & dosage | Anti-Retroviral Agents - adverse effects | Organophosphonates - adverse effects | Africa South of the Sahara | Adenine - administration & dosage | Pre-Exposure Prophylaxis | Organophosphonates - administration & dosage | Medication Adherence | Anti-Retroviral Agents - administration & dosage | Adolescent | HIV Infections - complications | Deoxycytidine - analogs & derivatives | Women | Care and treatment | HIV infection in women | Dosage and administration | HIV infection | Health aspects | Risk factors | Intervention | Creatinine | Antiretroviral drugs | Motivation | Human immunodeficiency virus--HIV | Prophylaxis | Vagina | Infections | Preventive medicine | Index Medicus | Abridged Index Medicus
Journal Article
JAMA internal medicine, ISSN 2168-6106, 01/2016, Volume 176, Issue 1, pp. 75 - 84
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Medication Adherence - statistics & numerical data | HIV Infections - prevention & control | Pre-Exposure Prophylaxis - methods | Prospective Studies | Reproductive Health | Humans | Middle Aged | Male | Community Health Services - methods | Adenine - blood | Young Adult | Homosexuality, Male | Adult | Anti-HIV Agents - therapeutic use | Female | Gonorrhea - epidemiology | District of Columbia | Adenine - analogs & derivatives | Tenofovir - therapeutic use | Organophosphates - blood | Sexual Behavior - statistics & numerical data | Syphilis - epidemiology | Chlamydia Infections - epidemiology | Bisexuality | Florida | San Francisco | Unsafe Sex - statistics & numerical data | Transgender Persons | Adolescent | Prevention | Care and treatment | Sexually transmitted diseases | HIV infection | MSM (Men who have sex with men) | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 5, pp. 672 - 677
pre-exposure prophylaxis | PrEP | HIV | United States | MSM | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Infections - prevention & control | United States - epidemiology | Cross-Sectional Studies | HIV Infections - epidemiology | Humans | Middle Aged | HIV Infections - psychology | Male | Patient Acceptance of Health Care - psychology | Patient Acceptance of Health Care - statistics & numerical data | Young Adult | Adolescent | Adult | HIV Infections - drug therapy | Homosexuality, Male - psychology | Homosexuality, Male - statistics & numerical data | Pre-Exposure Prophylaxis - statistics & numerical data | Practice guidelines (Medicine) | Care and treatment | MSM (Men who have sex with men) | Health aspects | HIV infection | Analysis | Mens health | Gays & lesbians | Preventive medicine | Human immunodeficiency virus--HIV | Risk factors | Sexual behavior | Index Medicus | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9977, pp. 1482 - 1484
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anti-HIV Agents - administration & dosage | Emtricitabine | Tenofovir | HIV Infections - prevention & control | Organophosphonates - administration & dosage | Adenine - analogs & derivatives | Health Services Accessibility | Deoxycytidine - administration & dosage | Humans | Deoxycytidine - analogs & derivatives | Adenine - administration & dosage | Pre-Exposure Prophylaxis | Medical ethics | Low income groups | Human rights | Infections | Preventive medicine | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
AIDS (London), ISSN 0269-9370, 07/2015, Volume 29, Issue 11, pp. 1277 - 1285
pre-exposure prophylaxis | adherence | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | HIV Infections - prevention & control | Medication Adherence | Pre-Exposure Prophylaxis - methods | Public Health | Humans | Anti-HIV Agents - therapeutic use | Male | Randomized Controlled Trials as Topic | Index Medicus | AIDS/HIV | PrEP
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2017, Volume 64, Issue 2, pp. 144 - 149
Tenofovir | TDF-FTC | PrEP | HIV | Preexposure prophylaxis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Infections - prevention & control | Pre-Exposure Prophylaxis - methods | History, 21st Century | United States | HIV Infections - history | Humans | Middle Aged | Male | Incidence | Insurance, Health - statistics & numerical data | Anti-HIV Agents - administration & dosage | Young Adult | Drug Prescriptions - statistics & numerical data | Adolescent | Adult | Female | HIV Infections - drug therapy | Databases, Factual | Prevention | Usage | Care and treatment | HIV infection | Health insurance | Antiretroviral drugs | Insurance coverage | Preventive medicine | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus
Journal Article